(lp0
S'How These Drug Makers Stocks are Faring? -- Orexigen Therapeutics, United ... Yahoo Finance - 18 hours ago For today, Stock-Callers.com draws attention to select Drug Manufacturers stocks, namely: Orexigen Therapeutics Inc. , United Therapeutics Corp.'
p1
aS"Blame This for Orexigen Therapeutics, Inc.'s Mind-Numbingly Bad 2015 Motley Fool - Jan 8, 2016 Shares of Orexigen Therapeutics , a biotechnology company focused on the development of therapies to induce weight loss, collapsed 72% in 2015, based on data from S&amp;P Capital IQ."
p2
aS'Orexigen Therapeutics Launches &quot;Brains Behind Weight Loss,&quot; a Dynamic Patient ... PR Newswire  - Jan 4, 2017 SAN DIEGO, Jan. 3, 2017 /PRNewswire/ -- Orexigen Therapeutics, Inc.  unveiled &quot;Brains Behind Weight Loss,&quot; a new, national direct-to-consumer advertising campaign demonstrating to patients how the brain plays an important role in weight&nbsp;...'
p3
aS'Orexigen Therapeutics to Present at the 35th Annual JP Morgan Healthcare ... PR Newswire  - Dec 19, 2016 SAN DIEGO, Dec. 19, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc.  today announced that the company will present at the 35th Annual J.P. Morgan Healthcare Conference 2017 in San Francisco. The presentation is scheduled for&nbsp;...'
p4
aS'Orexigen Therapeutics, Inc.  Looks Good For Further Gains Insider Financial - Jan 5, 2017 Orexigen Therapeutics, Inc.  is up 130% on its end of December close, with the company announcing that it is set to put out a fresh advertising for its lead  product.Orexigen Therapeutics Announces Publication of Contrave Orexigen Therapeutics  Releases Results Of IGNITE Study Through Obesity ... - StreetInsider.com'
p5
aS'Orexigen Therapeutics Announces Commercialization and Distributorship ... PR Newswire  - Aug 1, 2016 SAN DIEGO, Aug. 1, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc.  today announced that wholly owned subsidiary Orexigen Therapeutics Ireland Ltd.'
p6
aS'Orexigen Therapeutics Announces Commercialization and Distributorship ... PR Newswire  - Dec 8, 2016 SAN DIEGO, Dec. 8, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc.  today announced that its wholly owned subsidiary Orexigen Therapeutics Ireland Ltd.'
p7
aS'Orexigen Announces Presentation of Data for OREX-1019, a Preclinical Candidate ... PR Newswire  - Nov 16, 2016 SAN DIEGO, Nov. 16, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc.  today announced the presentation of preclinical data for OREX-1019  at Neuroscience 2016, the 46th annual meeting of the Society of Neuroscience, being&nbsp;...'
p8
aS"Orexigen Therapeutics Announces Stockholder Approval of All Proposals at 2016 ... PR Newswire  - Jul 8, 2016 The Board of Directors and stockholders approved a 1-for-10 reverse stock split of all of the outstanding shares of Orexigen's common stock. The Company expects that shares of Orexigen will begin trading on a post-split basis on July 12, 2016. At the ..."
p9
aS'Orexigen Therapeutics Announces Commercialization and Distributorship ... PR Newswire  - Nov 8, 2016 8, 2016 /PRNewswire/ -- Orexigen Therapeutics, Inc.  today announced that Valeant Pharmaceuticals International, Inc. , through a wholly owned subsidiary, will commercialize Contrave (naltrexone HCl / bupropion HCl extended&nbsp;...'
p10
a.